The Administrative Core is crucial to the operation of the Udall Center for Excellence in Parkinson Disease (PD) Research. It provides administrative, fiscal and scientific oversight of the other cores and the projects. It is responsible for maintaining a web page for reporting on scientific achievements of the center and for providing a portal for patient education. Core A, in conjunction with the other components of the Udall Center, assures that educational materials, data and research resources are available for sharing with other Udall Centers and with non-Udall PD investigators. Core A assures that the Udall Center will cooperate fully with NINDS initiatives, including submitting data and blood samples from familial PD to the Coriell Repository. Core A has a committed administrator who has experience with fiscal and administrative management of PD drug trials for the Movement Disorder Clinic, as well as experience in education and patient outreach. Core A will be responsible for, 1) fiscal management of the Udall Center, 2) insuring responsible conduct of research, and 3) promoting interactions between the Mayo Clinic and other Udall Centers. Moreover, it will provide scientific direction and accountability with the assistance of an External Advisory Committee. To accomplish these goals, the Administrative Core has the following specific aims:
Specific Aim 1. Provide administrative structure and support for the Udall Center.
Specific Aim 2. Establish an Executive Committee and a committee of internal advisors to assist in scientific administration and oversight of fiscal and personnel matters.
Specific Aim 3. Establish an External Advisory Committee, conduct annual meetings and report progress and critiques to the NINDS.
Specific Aim 4. Assume responsibility for quality control of the activities of the Udall Center and ensure the safety of human subjects.
Specific Aim 5. Promote collaborative interactions between Mayo Clinic and other Udall Centers.
Specific Aim 6. Ensure that the clinical research conforms to the standards of the ethical conduct of research and is compliant with HIPAA guidelines.
Specific Aim 7. Maintain a Web page to report center progress and to promote information transfer as well as patient and professional education.
Specific Aim 8. Provide training experiences for trainees in genetics, neurobiology, neurology, neuropsychology, psychiatry, neuroradiology, neuropathology and other disciplines, as well as a multidisciplinary didactic curriculum related to PD and related neurodegenerative disorders and support for scientist development for faculty and trainees.

Public Health Relevance

Core A provides essential services and oversight for the Udall Center, assuring compliance with federal regulations, as well as fiscal accountability and regular reporting of progress on research aims to the NINDS. Core A also fosters collaborations between Mayo Clinic and other Udall Centers and it promotes patient and professional education through outreach efforts, formal teaching courses, regular seminar series and an interactive web page.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1-SRB-J)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic Jacksonville
United States
Zip Code
Kertesz, A; Finger, E; Murrell, J et al. (2015) Progressive supranuclear palsy in a family with TDP-43 pathology. Neurocase 21:178-84
Kalia, Lorraine V; Lang, Anthony E; Hazrati, Lili-Naz et al. (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100-5
Sundal, C; Baker, M; Karrenbauer, V et al. (2015) Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. Eur J Neurol 22:328-33
Fujioka, Shinsuke; Sanchez Contreras, Monica Y; Strongosky, Audrey J et al. (2015) Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. Parkinsonism Relat Disord 21:101-5
Bieniek, Kevin F; van Blitterswijk, Marka; Baker, Matthew C et al. (2014) Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia. JAMA Neurol 71:775-81
Bras, Jose; Guerreiro, Rita; Darwent, Lee et al. (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139-46
Ross, Jay P; Rayaprolu, Sruti; Bernales, Cecily Q et al. (2014) SLC1A2 rs3794087 does not associate with essential tremor. Neurobiol Aging 35:935.e9-10
Heckman, Michael G; Elbaz, Alexis; Soto-Ortolaza, Alexandra I et al. (2014) Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging 35:266.e5-14
Angeles, Dario C; Ho, Patrick; Chua, Ling Ling et al. (2014) Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila. Hum Mol Genet 23:3157-65
Bailey, Rachel M; Howard, John; Knight, Joshua et al. (2014) Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Mol Neurodegener 9:8

Showing the most recent 10 out of 127 publications